CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Expedition gets another $115M for its twist on China NewCo model

Positive
AI Analysis

Summary

Expedition Therapeutics raised $115 million in Series B funding for its China-sourced COPD drug candidate using a variant of the NewCo model.

Importance:6/10
Sentiment:
0.60
fundingSeries BChina NewCo modelCOPD
Related Companies

Read the original article

Published by Endpoints News on August 5, 2026 12:00 PM

Read Original